Remove topic infectious-disease
article thumbnail

Antimicrobial Stewardship in Turkey – A Clinical Pharmacist’s Perspective

ID Stewardship

In this article, a pharmacist from Turkey with advanced training in the area of infectious diseases provides insights on antimicrobial stewardship in Turkey. During our bedside patient follow-up, we ran into an infectious diseases (ID) consultant who was following some of the ward patients. Interview with: Emre Kara, MSc.,

article thumbnail

5 Things I Love About The MAD-ID Conference, The Antimicrobial Stewardship Meeting

ID Stewardship

In this article an infectious diseases pharmacists discusses the MAD-ID conference, which is known as The Antimicrobial Stewardship Meeting, Making A Difference In Infectious Diseases (MAD-ID). Scroll to the bottom of this post for a list of infectious diseases meetings that have been sourced from Twitter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Partnering With Microbiology Laboratory To Bring Awareness To Antimicrobial Resistance

ID Stewardship

In this article three infectious diseases pharmacists discuss the cross-roads of antimicrobial resistance and microbiology laboratory, reflecting on a recent Twitter chat on the topic. ABOUT THE AUTHORS Patrick McDaneld, PharmD, BCIDP is a medical science liaison at bioMérieux, focused on clinical infectious diseases.

article thumbnail

RVAC Medicines, A*STAR partner for mRNA manufacturing expertise

Pharmaceutical Technology

This will aid in the production of new raw materials and possible clinical-grade assets to develop mRNA vaccines and therapies for infectious diseases, as well as other ailments with unmet needs. RVAC is currently developing mRNA-based vaccines against infectious diseases such as Covid-19.

article thumbnail

SK bioscience and CEPI enter mRNA vaccine development deal

Pharmaceutical Technology

SK bioscience has signed a new collaboration agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger ribonucleic acid (mRNA) vaccines for infectious diseases. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). Topic sponsors are not involved in the creation of editorial content.

article thumbnail

2022 IDstewardship Year End Review

ID Stewardship

This Infectious Diseases Pharmacist Went Viral On Social Media – You’ll Never Guess Why. Insights On Designing Useful Guidelines For Infectious Diseases. Dessert Before Dinner: How To Sweeten Up Pharmacy Topic Discussions For Your Learners. The Top 100 Twitter Influencers in Infectious Diseases.